Improving Real-World Mortality Data Quality in Oncology Research: Augmenting Electronic Medical Records With Obituary, Social Security Death Index, and Commercial Claims Data An online survey was ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...

The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s ...

Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...

Synthetic control arms may help tackle the unique complexities, but key challenges such as data access and standardisation ...

Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Clinical trial attrition can be detrimental to clinical outcomes, patient well-being and the financial health of research programs. Clinical trial dropout rates, which range from 15% to 40%, greatly ...

Challenges in clinical trials are unique to each therapeutic area, whether patient recruitment or regulatory compliance. For example, oncology trials require precise endpoint definitions, while ...